Kaken Pharmaceutical Statistics
Total Valuation
KKPCF has a market cap or net worth of 989.15 million. The enterprise value is 532.01 million.
Market Cap | 989.15M |
Enterprise Value | 532.01M |
Important Dates
The last earnings date was Monday, May 12, 2025.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Current Share Class | 37.87M |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.13% |
Shares Change (QoQ) | +3.06% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 32.67M |
Valuation Ratios
The trailing PE ratio is 10.62.
PE Ratio | 10.62 |
Forward PE | n/a |
PS Ratio | 1.58 |
PB Ratio | 0.97 |
P/TBV Ratio | 1.11 |
P/FCF Ratio | 5.78 |
P/OCF Ratio | 4.97 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.27, with an EV/FCF ratio of 3.11.
EV / Earnings | 5.71 |
EV / Sales | 0.82 |
EV / EBITDA | 3.27 |
EV / EBIT | 3.66 |
EV / FCF | 3.11 |
Financial Position
The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.03.
Current Ratio | 3.67 |
Quick Ratio | 3.01 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.16 |
Debt / FCF | 0.15 |
Interest Coverage | 751.28 |
Financial Efficiency
Return on equity (ROE) is 9.41% and return on invested capital (ROIC) is 8.65%.
Return on Equity (ROE) | 9.41% |
Return on Assets (ROA) | 7.26% |
Return on Invested Capital (ROIC) | 8.65% |
Return on Capital Employed (ROCE) | 13.14% |
Revenue Per Employee | 553,264 |
Profits Per Employee | 82,047 |
Employee Count | 1,135 |
Asset Turnover | 0.52 |
Inventory Turnover | 1.96 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.09% in the last 52 weeks. The beta is 0.03, so KKPCF's price volatility has been lower than the market average.
Beta (5Y) | 0.03 |
52-Week Price Change | +20.09% |
50-Day Moving Average | 27.43 |
200-Day Moving Average | 27.10 |
Relative Strength Index (RSI) | 97.49 |
Average Volume (20 Days) | 5 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KKPCF had revenue of 627.96 million and earned 93.12 million in profits. Earnings per share was 2.44.
Revenue | 627.96M |
Gross Profit | 390.88M |
Operating Income | 140.48M |
Pretax Income | 129.78M |
Net Income | 93.12M |
EBITDA | 157.53M |
EBIT | 140.48M |
Earnings Per Share (EPS) | 2.44 |
Balance Sheet
The company has 468.02 million in cash and 25.71 million in debt, giving a net cash position of 442.31 million.
Cash & Cash Equivalents | 468.02M |
Total Debt | 25.71M |
Net Cash | 442.31M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.02B |
Book Value Per Share | 26.54 |
Working Capital | 541.06M |
Cash Flow
In the last 12 months, operating cash flow was 198.87 million and capital expenditures -27.63 million, giving a free cash flow of 171.23 million.
Operating Cash Flow | 198.87M |
Capital Expenditures | -27.63M |
Free Cash Flow | 171.23M |
FCF Per Share | n/a |
Margins
Gross margin is 62.25%, with operating and profit margins of 22.37% and 14.83%.
Gross Margin | 62.25% |
Operating Margin | 22.37% |
Pretax Margin | 20.67% |
Profit Margin | 14.83% |
EBITDA Margin | 25.09% |
EBIT Margin | 22.37% |
FCF Margin | 27.27% |
Dividends & Yields
This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 4.87%.
Dividend Per Share | 1.30 |
Dividend Yield | 4.87% |
Dividend Growth (YoY) | 30.75% |
Years of Dividend Growth | 1 |
Payout Ratio | 51.62% |
Buyback Yield | -1.13% |
Shareholder Yield | 3.75% |
Earnings Yield | 9.41% |
FCF Yield | 17.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KKPCF has an Altman Z-Score of 4.8.
Altman Z-Score | 4.8 |
Piotroski F-Score | n/a |